Nguyen Manh Thang
Chief Executive Officer, AgileTech Vietnam
- Published
- Read time
- 10 min
In short
A mental health app succeeds on three tests most builders underweight. Clinical seriousness: crisis detection and response flows, validated measurement instruments like the PHQ-9 and GAD-7 tracked over time, and escalation paths to human care, built in from the first version, because a mental health product without them is a liability wearing a calming color palette. Engagement: mental health apps suffer the steepest retention decay in consumer software, and the products that work invest in therapeutic relationship, habit architecture and content depth rather than feature count. And privacy: mental health data is the most sensitive category there is, demanding HIPAA-grade or better architecture and a business model that never monetizes the data. A credible MVP spanning mood tracking, a program of therapeutic content, measurement and crisis flows runs 150,000 to 350,000 dollars over 4 to 7 months; teletherapy and blended-care platforms run 400,000 to 900,000 and up.
Mental health apps carry a double burden. They are health software, with everything this cluster says about compliance, clinical workflow and safety applying in full. And they are consumer engagement products in the hardest retention category there is, serving users whose condition itself, low motivation, avoidance, crisis episodes, works against the habit loops that consumer software relies on. Most mental health apps fail on one side or the other: clinically hollow wellness content that engages briefly and helps little, or clinically earnest tools that nobody opens twice.
This guide is for teams building past both failure modes. It maps the product landscape, self-guided, coaching, teletherapy, blended care, because the type decides the regulatory tier, the staffing and the economics. It details the clinical safety machinery that any serious product ships in version one, the feature scope and cost arithmetic by tier, the privacy architecture that mental health data demands, and the engagement engineering that decides whether the rest matters. Costs and timelines are planning bands from real project shapes, not quotes.
It slots into this cluster's healthcare arc: teletherapy products inherit the telemedicine platform guide's machinery, video visits, clinician networks, e-prescribing, licensing-aware routing, while the measurement and device threads connect to the remote monitoring guide. This page covers what mental health adds and changes on top of those foundations.
Key takeaways
- Pick the product type first: self-guided tools, coaching platforms, teletherapy, and blended care are four different businesses with different regulatory, clinical and staffing consequences.
- Crisis flows are not optional: detection signals, an always-reachable crisis path, and jurisdiction-correct hotline routing belong in version one of anything that touches mental health.
- Measurement-based care is the credibility line: validated instruments (PHQ-9, GAD-7) administered on schedule and trended over time separate clinical products from wellness content.
- Engagement is the real boss fight: median mental health app retention collapses within two weeks, and the winners engineer therapeutic alliance, habit loops and content depth deliberately.
- Mental health data sets the privacy bar above general health data: architecture, vendor chain and business model must all survive the question "what happens to a disclosure about suicidal ideation?"
- A credible self-guided MVP runs 150,000 to 350,000 dollars over 4 to 7 months; teletherapy platforms inherit the full telemedicine stack and run 400,000 to 900,000 and beyond.
The product landscape: four types, four businesses
Self-guided products, mood tracking, journaling, meditation and CBT-based programs delivered as interactive content, are the accessible tier: no clinician network, no visit infrastructure, consumer or employer distribution, and the lightest regulatory posture as long as claims stay on the wellness side of the line. Their economics are subscription consumer software; their hard problem is pure engagement; and their ceiling is real but bounded, because self-guided tools serve mild-to-moderate needs and must recognize, honestly and by design, the users who need more. The best products in this tier treat that recognition as a feature: screening that detects severity and routes upward rather than retaining a user the product cannot help.
Coaching platforms add humans without adding licensed clinical care: trained coaches, structured programs, messaging-first relationships, often employer-sponsored. The type inherits a marketplace problem, recruiting, training, scheduling and quality-managing a coach network, and a boundary problem that is genuinely load-bearing: coaches are not therapists, the product must enforce scope-of-practice boundaries in its workflows, and the escalation path from coach to licensed care must be designed, staffed and drilled. Blurring this line is the type's signature failure, commercially and ethically, and regulators have begun to notice.
Teletherapy platforms are licensed clinical care over the telemedicine stack: therapists and psychiatrists, video sessions, clinical documentation, measurement-based care, prescribing where psychiatry is in scope, and insurance billing where the model reaches for it. Everything the telemedicine platform guide describes applies: licensing-aware routing, EHR-grade record keeping, e-prescribing rails with controlled-substance rules that matter acutely in psychiatry, and clinical-channel reliability. Mental health adds its own layers: session cadences and therapeutic-relationship continuity that scheduling must protect, outcome measurement as clinical practice, and a no-show and crisis-coverage reality that operations must staff for.
Blended care is the maturing edge: programs that combine self-guided content, coaching or therapy sessions, measurement, and sometimes psychiatry, in one care pathway, stepped by severity, the digital version of what clinical literature calls stepped care. It is the hardest type to build, it contains the other three, and the most defensible: outcomes are demonstrably better when human care and digital tools reinforce each other, employers and payers increasingly buy on measured outcomes, and the care pathway itself, who steps up, when, triggered by what measurement, becomes the product's clinical intellectual property. Teams usually arrive here by expansion from one of the simpler types rather than starting here, and the architecture should anticipate that expansion even when version one does not include it.
The four types, compared
| Type | Contains | Regulatory posture | Defining problem |
|---|---|---|---|
| Self-guided | Tracking, programs, content | Wellness claims; privacy law | Engagement, honestly bounded scope |
| Coaching | Coach network, messaging, programs | Scope-of-practice boundaries | Coach quality and the escalation line |
| Teletherapy | Licensed care, video, records, eRx | Full clinical: HIPAA, licensing, prescribing | The telemedicine stack plus continuity |
| Blended care | All of the above, stepped by severity | Full clinical plus outcome claims | The care pathway as product |
The mental health product types as different businesses: what each contains, its regulatory posture, and its defining hard problem.
Clinical safety: the machinery version one must ship
Crisis capability comes first, and it is not a settings-page link. A serious product designs for the moment a user is in danger: detection signals, explicit statements in journals or messages, instrument scores crossing thresholds, the suicidality item on the PHQ-9 above all, and behavioral flags where models are used, with humility about their limits; an always-reachable crisis path, visible from every screen, that routes to crisis lines correctly per the user's jurisdiction, 988 in the US, national equivalents elsewhere; and a defined response protocol behind the detection, what the product does, what humans do, on what clock, written with clinical advisors and rehearsed like the incident process it is. Products with human care add duty-of-care obligations: crisis coverage between sessions, and clinician alerting when a patient's signals deteriorate.
Measurement-based care is the second pillar and the credibility line between clinical products and wellness content. The instruments are standard and free to use correctly: the PHQ-9 for depression, the GAD-7 for anxiety, administered on a schedule, scored properly, trended over time, and, in products with clinicians, surfaced in the clinical workflow so treatment actually adjusts to the data, which is the whole point of the practice and the thing traditional care does far less than it should. Engineering-wise this is easy; clinically it is discipline: correct administration windows, response to threshold crossings including the crisis item, and honest presentation of trends to users, whose relationship with their own data is itself therapeutic material.
The escalation architecture ties safety together across every product type: the routing logic that moves a user from self-guided content to a coach, from a coach to a therapist, from a therapist to psychiatry or crisis care, triggered by measurement, by human judgment, or by the user asking. Each hop has product mechanics, availability, warm handoff, context transfer so the user does not restart their story, and each has an accountability answer: who is clinically responsible for this user right now? Products that cannot answer that question at every moment have a gap exactly where the stakes are highest. This is also where scope honesty lives: marketing that implies therapy while delivering content is not just a compliance risk, it recruits users the product cannot serve into the gap.
Around these pillars sits the clinical governance that serious products run: licensed clinical leadership accountable for protocols, clinical advisors in the design loop from sprint one rather than the pilot postmortem, content review by qualified clinicians for anything therapeutic, and adverse-event processes that treat safety failures with incident discipline. Where AI enters, chat-based support, journaling analysis, triage suggestions, governance tightens further: clinical review of model behavior, hard guardrails around crisis content, no unsupervised model ever holding the crisis conversation, and honest disclosure to users about what is and is not human. The industry's cautionary tales here are recent and public, and the bar they set is a design input.
The version-one safety checklist
- Crisis path from every screenJurisdiction-correct hotline routing, one tap away, tested like payments code.
- Detection with a protocol behind itInstrument thresholds, explicit statements, the PHQ-9 crisis item: each with a written, rehearsed response.
- Validated instruments, correctly runPHQ-9, GAD-7 on schedule, scored right, trended, and acted on: measurement-based care, not decoration.
- Escalation with accountabilityContent to coach to therapist to crisis care, warm handoffs, and a clear answer to "who is responsible now?"
- Clinical governance from sprint oneLicensed clinical leadership, clinician content review, adverse-event discipline.
- AI guardrails where models touch usersClinically reviewed behavior, hard crisis guardrails, no unsupervised model in the crisis conversation.
The engagement problem: retention is the clinical outcome
The numbers deserve stating plainly: consumer mental health apps show some of the steepest retention decay in software, with median products losing the large majority of users within two weeks and single-digit percentages active at thirty days. And in this category, retention is not a growth metric; it is a clinical one, because therapeutic programs deliver outcomes through sustained practice, and an app abandoned in week one helped nobody. The engagement problem is therefore the central product problem, and it is harder here than anywhere in consumer software because the condition itself fights the habit: depression suppresses motivation, anxiety fuels avoidance, and the moments users most need the product are the moments they are least likely to open it.
What works has converged across the products with published outcomes. Therapeutic alliance, the felt relationship with a human or a credibly caring program, is the strongest engagement force in the category: products with even light human touch, a coach's weekly message, a therapist's continuity, retain multiples better than pure self-serve tools, which is a staffing cost worth pricing before assuming a software-only model. Habit architecture does the daily work: tiny default actions, a two-minute check-in rather than a twenty-minute module, streaks and gentle recovery from broken streaks, notifications that are timed to the user's actual patterns and never guilt-toned. And content depth prevents the three-week cliff: a program that runs out of meaningful material trains its own churn.
Personalization is the compounding layer. Severity-based routing from the first session, the measurement machinery doing double duty, so a mild-symptom user and an acute one see different products; content sequencing that adapts to what the user engages with and reports helps; and the moment-of-need design that makes the app useful in a panic spiral at 2 AM, not just in scheduled practice, which is where brief interventions, grounding exercises, crisis-adjacent tools, earn their place on the home screen. The measurement data doubles as engagement telemetry with an ethical constraint attached: optimizing engagement is legitimate exactly insofar as engagement serves outcomes, and dark-pattern retention mechanics in a mental health product are both wrong and, increasingly, regulatory exposure.
The business model interacts with engagement more tightly here than in most categories. Consumer subscription models live and die on the retention curves above, which is why the center of commercial gravity has shifted toward employer and payer distribution: benefits programs buy on population outcomes rather than individual streaks, tolerate episodic usage patterns that consumer economics cannot, and fund the human layers that retention needs. The design consequence runs backward into the product: employer-distributed products need engagement reporting at population level, privacy-preserving by construction, because the employer must never see an individual's data, and clinical outcome reporting that survives a benefits consultant's diligence. Engagement, in other words, is not a growth-team afterthought; it is load-bearing across clinical outcomes, ethics and revenue at once.
Feature scope and cost, tier by tier
The self-guided MVP that clears this guide's bars contains more than most first specs: onboarding with severity screening and consent that is actually readable; mood and symptom tracking designed for two-minute dailies; a structured therapeutic program, CBT-based modules being the evidence-backed default, with enough content depth to outlast the early cliff; the measurement loop, PHQ-9 and GAD-7 on schedule with trends; the crisis machinery from the safety section, non-negotiable; and the habit layer, reminders, streaks, moment-of-need tools. Built by a compact senior team with clinical advisors, this lands at 150,000 to 350,000 dollars over 4 to 7 months, the range driven mostly by content production, real therapeutic content is expensive to write, review and produce, and by how much personalization version one attempts.
The coaching tier adds the human infrastructure: coach-facing workspaces with caseloads, messaging with clinical-grade privacy, scheduling, program assignment and progress visibility; the boundary and escalation machinery, scope-of-practice guardrails in the workflow itself; and the operational tooling, coach onboarding, quality review, supervision notes, that a network needs. The build adds 100,000 to 250,000 dollars over the self-guided base, and the deeper cost is operational: recruiting, training and quality-managing the coach network is a permanent function whose economics, coach utilization, caseload ratios, dominate the P&L far beyond the software line.
The teletherapy tier inherits the telemedicine platform bill of materials: video infrastructure under BAA, clinician scheduling with licensing-aware routing, clinical documentation and a record that is EHR-grade even if not an EHR, e-prescribing with the controlled-substance tier where psychiatry is in scope, insurance eligibility and claims where the model bills payers, and the reliability engineering of a clinical channel. Built assembled, rails bought, workflow owned, the full platform runs 400,000 to 900,000 dollars over 9 to 15 months, consistent with the telemedicine platform arithmetic, with psychiatry's prescribing rules and the therapy-specific continuity mechanics as the mental-health-specific additions. Blended care stacks the tiers and adds the pathway engine, stepping logic, measurement triggers, care-team coordination, typically an additional 150,000 to 300,000 over the platform base.
Two lines recur across every tier and deserve their own budget rows. Content and clinical governance: therapeutic content production with clinician review runs 50,000 to 150,000 for a credible launch library and continues forever, and clinical leadership, fractional at first, is a standing cost, not a consultancy line. And the annual run rate: the 25 to 40 percent of build cost that healthcare platforms carry for compliance, vendor rails, and integration maintenance applies here in full, with content refresh on top. Teams budgeting only the software build are budgeting roughly two-thirds of the real number, which is the polite version of the most common mental health startup surprise.
The cost bands, by tier
Privacy: the highest bar in health data
Mental health data is the most sensitive category in consumer software, full stop: therapy transcripts, journal entries, suicidality scores, psychiatric prescriptions. A breach or misuse here is not an inconvenience; it affects employment, insurance, custody, relationships and safety. The architecture bar starts at the healthcare baseline this cluster has established, encryption everywhere including analytics paths, relationship-based access control, immutable audit, BAAs across the vendor chain, and rises: content-level protections for journals and messages, end-to-end encryption where the care model permits it; data minimization as a design principle, collect what the care requires, not what the roadmap might someday want; and retention and deletion machinery that actually works, because "delete my account" must mean it here.
The regulatory surface is broader than teams expect. HIPAA covers the product when a covered entity or its business associates are in the loop, teletherapy, employer clinical programs, but plenty of consumer mental health apps sit outside HIPAA, and regulators have moved into that gap: the FTC has acted against mental health apps for sharing user data with advertisers, US states have passed consumer health-data laws with private rights of action, and GDPR treats health data as a special category with explicit-consent requirements. The safe posture is to build to the strictest plausible standard regardless of technical coverage, because the reputational standard is absolute: the first headline about a therapy app leaking data to ad networks is the last headline that product gets.
The business model is a privacy decision, and users and regulators have both learned to ask. Advertising-funded mental health products carry a structural conflict this category cannot sustain: the data is too sensitive to monetize, the trackers embedded in ad stacks leak by design, and the enforcement actions of recent years nearly all trace to exactly this pattern. Subscription, employer and payer models align incentives correctly, with the employer model adding its own hard rule, individual data never reaches the employer, population reporting is aggregated and anonymized with minimum cohort sizes, and the product's privacy story is part of the benefits sales motion. Writing the data policy is not a legal task to schedule before launch; it is a product decision that shapes architecture from the first sprint.
AI raises the stakes again, because the useful applications, conversation support, journaling insight, session summarization for therapists, all involve running models over the most sensitive text a person produces. The disciplines that make it defensible: processing under BAAs with no training on user data as the default and contractual rule, transparency to users about what models see and do, human review boundaries so model outputs inform clinicians rather than replace them, and the crisis guardrails from the safety section wherever a model faces a user directly. Teams that treat these as product constraints from day one build defensible AI features; teams that bolt models onto sensitive data flows are running an enforcement lottery with their users' worst moments as the stake.
The privacy posture, concretely
Do this
- Build to the strictest plausible standardHIPAA-grade architecture whether or not HIPAA technically applies. The reputational standard is absolute.
- Minimize and actually deleteCollect what care requires. Retention limits and deletion that works, including backups and vendors.
- Aggregate employer reportingPopulation outcomes with minimum cohort sizes. An individual's data never reaches their employer.
- Constrain AI contractually and by designBAAs, no training on user data, human review boundaries, crisis guardrails on anything user-facing.
Not this
- Fund it with advertisingAd stacks leak by design and the enforcement record is unambiguous. This category cannot carry that model.
- Embed consumer analytics casuallyThird-party SDKs in a mental health app are data flows to audit, not defaults to accept.
- Treat the privacy policy as legal boilerplateIt is a product decision that shapes architecture, and users in this category actually read it.
- Let models near crisis conversations unsupervisedThe cautionary tales are public and recent. Hard guardrails, human escalation, no exceptions.
The build: team, sequence, and the clinical thread
The team shape follows the double burden. The software side is a compact senior product team, the mobile discipline the mobile team guide describes applies directly, since mental health products live on phones: 4 to 8 engineers across mobile and backend, design with real consumer-product depth, because this category's UX bar is set by the best consumer apps, not by healthcare, and QA that covers the safety flows like the life-critical paths they are. The clinical side is not advisory garnish: licensed clinical leadership with real authority over protocols and content, therapist and user research access throughout, and content production capacity, writers plus clinician reviewers, as a standing function. Healthcare-experienced engineers matter here as everywhere in this cluster, and the sourcing patterns, a permanent core plus specialized delivery capacity, apply unchanged.
The sequence that works starts with the spine, not the surface: measurement, crisis machinery and the care-loop skeleton first, because everything else hangs on them and retrofitting safety reads exactly as cynical as it is. Then the daily-use loop, check-in, content, habit layer, iterated against real users early, because engagement assumptions do not survive contact and the two-week cliff shows up in week two of any honest beta. Then the tier-specific machinery, coach workspaces, or the teletherapy stack, built assembled on bought rails. Clinical review gates every release that touches therapeutic content or safety flows, and the beta program runs with the seriousness of a clinical pilot: defined cohorts, measured outcomes, adverse-event tracking, and clinical supervision of whatever the product surfaces.
Evidence strategy is a build decision with long shadows. Products claiming clinical outcomes need data: at minimum, real-world outcome tracking through the measurement machinery, published transparently; for stronger claims and payer conversations, formal studies, pilots with employer cohorts, academic partnerships, and for products crossing into treatment claims for specific conditions, the regulated digital-therapeutics path with its trials and submissions. The strategic point for builders: the measurement-based care machinery this guide made mandatory is also the evidence engine, and products that instrument outcomes honestly from launch accumulate the dataset their future claims, sales motions and possibly regulatory filings will need. Evidence is not a phase after product-market fit; in this category it is a component of it.
The honest closing frame: mental health software is worth building carefully because the need is vast, untreated need dwarfs clinical capacity in every market, and digital products genuinely extend reach when they are clinically serious and actually used. The failure modes are equally real: wellness veneer over nothing, engagement mechanics without care underneath, data practices that betray exactly the trust the category runs on. The guide's three tests, clinical seriousness, engagement engineering, privacy as architecture, are the difference, and they are all buildable by teams that take them as requirements rather than aspirations. That is the standard the category deserves, and increasingly the one its regulators, buyers and users enforce.
The build sequence, gated
-
The spine firstMonths 1 to 2
Measurement instruments, crisis machinery, care-loop skeleton. Safety is architecture, not a later feature.
-
The daily loop, against real usersMonths 2 to 5
Check-in, program content, habit layer, iterated in honest beta where the two-week cliff is visible.
-
The tier machineryMonths 4 to 8
Coach workspaces or the teletherapy stack on bought rails, with clinical review gating every safety-adjacent release.
-
Evidence from day oneStanding
Outcome tracking through the measurement engine, clinical-pilot discipline in beta, the dataset future claims will need.
The decision frame: choosing your lane and your first version
The lane decision routes on two questions: whether humans deliver care in your model, and whether those humans are licensed clinicians. No humans: self-guided, the fastest lane to market, bounded scope, engagement as the whole game, and honesty about severity routing as the ethical price of the simplicity. Humans, not licensed: coaching, with the network operations and the boundary machinery as the real product. Licensed clinicians: teletherapy, inheriting the full clinical stack, with psychiatry's prescribing rules as a further gate worth deciding explicitly, since medication support changes the regulatory, clinical and operational posture all at once. Blended care is not a starting lane; it is where successful products in any lane converge, and the architecture decision worth making early is simply not to preclude it.
The distribution decision interacts with the lane and deserves equal weight. Direct-to-consumer distribution means consumer acquisition costs against the category's brutal retention curves, viable for products with genuine habit-forming strength and clear willingness to pay, punishing for everything else. Employer and benefits distribution trades sales-cycle length for durable contracts, funds human care layers, and demands outcome reporting and privacy architecture as sales collateral. Payer and health-system distribution is the deepest water: credentialing, billing integration, clinical evidence expectations, and timelines measured in years, with the reward of reimbursement-scale economics. First-time teams generally survive best starting employer-distributed or consumer-with-employer-ambitions, because the middle route funds clinical seriousness before demanding payer-grade evidence.
The first-version scope test, after lane and distribution are chosen, is a single question applied ruthlessly: does this feature serve the spine, safety, measurement, the daily loop, or is it roadmap decoration? Mental health specs accumulate decoration faster than most, mood-face animations, social features that create moderation obligations, gamification that reads as trivializing, AI chat because it demos well, and each decoration competes for budget with content depth and safety machinery that actually move outcomes. The products that win their first year ship a narrow spine with unusual depth: fewer features, more content, safety that works, measurement that means something, and an engagement loop refined against real users rather than expanded against a slide deck.
And the capability question, build with whom: the profile is the intersection this cluster keeps describing, consumer-grade product craft, healthcare-grade compliance reflexes, and clinical governance woven through both, which almost no single team holds natively. The workable pattern is the one this guide's neighbors detail: a permanent core owning the clinical product vision and the user relationship, specialized delivery capacity for the engineering surface, sourced against regulated-domain portfolios, and clinical leadership retained like the co-founder-grade function it is. Built that way, on the sequence above, a mental health product can be clinically serious, genuinely engaging and privacy-sound at once, which is simply the definition of the products this category has been waiting for.
Frequently asked questions
How much does it cost to build a mental health app?
By tier: a credible self-guided MVP, tracking, a CBT-based program, PHQ-9 and GAD-7 measurement, crisis machinery and a habit layer, runs 150,000 to 350,000 dollars over 4 to 7 months, with content production driving much of the range. Coaching adds 100,000 to 250,000 plus permanent network operations. Teletherapy platforms inherit the full telemedicine stack at 400,000 to 900,000. Every tier carries 25 to 40 percent of build cost annually for compliance, rails and content refresh.
What features does a mental health app need in version one?
The spine before anything else: severity screening at onboarding, a crisis path reachable from every screen with jurisdiction-correct hotline routing and a written response protocol, validated instruments (PHQ-9, GAD-7) administered on schedule and trended, and escalation paths to human care. Then the daily loop: two-minute check-ins, structured therapeutic content deep enough to outlast week three, and habit architecture. Decorative features compete with this spine for budget and usually lose users.
Do mental health apps need to be HIPAA compliant?
When a covered entity or business associate is in the loop, teletherapy, employer clinical programs, yes, in full. Many consumer apps sit outside HIPAA technically, but regulators have filled the gap: FTC enforcement against apps sharing data with advertisers, state consumer health-data laws, and GDPR's special-category rules. The defensible posture is building to HIPAA-grade architecture regardless, with data minimization, real deletion, and no advertising-funded model, because the reputational standard is absolute.
Why do mental health apps have such poor retention?
The category fights itself: depression suppresses motivation, anxiety fuels avoidance, and users most need the product in the moments they are least likely to open it. Median apps lose most users within two weeks. What bends the curve: human touch and therapeutic alliance above all, tiny-default habit loops, content depth that outlasts the early cliff, moment-of-need tools that work at 2 AM, and severity-based personalization from the first session. In this category, retention is a clinical outcome, not a growth metric.
What is measurement-based care and why does it matter in an app?
The practice of administering validated instruments, the PHQ-9 for depression, the GAD-7 for anxiety, on a schedule, trending the scores, and adjusting care based on the data. In an app it is the credibility line between clinical products and wellness content: it powers severity routing and escalation triggers, gives users an honest view of their trajectory, surfaces deterioration including the crisis item, and accumulates the outcome dataset that employer sales, payer conversations and any future regulatory claims will require.
Can AI safely be used in mental health apps?
In constrained roles with hard guardrails: journaling insight, session summarization for clinicians, content personalization, all under BAAs with no training on user data, transparency about what models see, and human review boundaries. The bright line is crisis: no unsupervised model should hold a crisis conversation, detection signals route to human protocols, and user-facing model behavior gets clinical review before release. The category's public cautionary tales all trace to skipping exactly these constraints.
Mental health apps fail on two fronts at once: clinically hollow content that engages briefly, or earnest tools nobody opens twice. To build past both, read the mental health app guide, covering crisis machinery, measurement-based care, the engagement problem and the tier-by-tier cost bands.
